1992
DOI: 10.1016/0140-6736(92)92527-m
|View full text |Cite
|
Sign up to set email alerts
|

Role of glucose and insulin resistance in development of type 2 diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and insulin secretion disorders [ 22 , 23 ]. Many studies have demonstrated that insulin resistance precedes β cell defects [ 24 , 25 ], which first occurs in skeletal muscle. Glucose transporter protein 4 (GLUT4) is an insulin-responsive glucose transporter protein [ 26 , 27 ].…”
Section: Differences In Pathogenesis Of Different Types Of Diabetes M...mentioning
confidence: 99%
“…Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and insulin secretion disorders [ 22 , 23 ]. Many studies have demonstrated that insulin resistance precedes β cell defects [ 24 , 25 ], which first occurs in skeletal muscle. Glucose transporter protein 4 (GLUT4) is an insulin-responsive glucose transporter protein [ 26 , 27 ].…”
Section: Differences In Pathogenesis Of Different Types Of Diabetes M...mentioning
confidence: 99%
“…The prolonged asymptomatic phase of T2DM may last years, during which time unmanaged elevated blood glucose could lead to serious and irreversible micro- and macrovascular complications including neuropathy, nephropathy, retinopathy, coronary artery disease, stroke, and peripheral vascular disease [ 3 , 4 ]. Although the underlying cause has not been fully clarified, it is generally attributed to insulin resistance (IR), which precedes formal diagnosis of T2DM for years [ 5 ]. It has been well established that both insulin resistance and obesity play an important role in the pathogenesis of T2DM [ 6 ] and therefore their amelioration is a critical clinical goal.…”
Section: Introductionmentioning
confidence: 99%